Home | All results_reference

[RDF data]
Results Reference #1336

Resource URI: http://static.linkedct.org/resource/results_reference/1336
linkedct:citation Pacey SC, Wilson RH, Walton M, et al.: A phase I trial of the heat shock protein 90 (HSP90) inhibitor alvespimycin (17-dimethylaminoethylamino-17-demethoxygeldanamycin 17-DMAG) administered weekly, intravenously, to patients with advanced solid tumors. [Abstract] American Association for Cancer Research: Molecular Targets and Cancer Therapeutics, October 22-26, 2007, San Francisco, CA A-PR-6, 2007.
rdfs:label Results Reference #1336
is linkedct:results_reference of <http://static.linkedct.org/resource/trials/NCT00248521>
linkedct:results_reference_id 1336 (xsd:int)
rdf:type linkedct:results_reference